| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |